Medicine and Dentistry
Patient
100%
Acute Promyelocytic Leukemia
58%
Disease
58%
Molecular Pathology
58%
Aortic Valve
58%
Clinical Management
58%
Prosthetics
58%
1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine
58%
Parkinson's Disease
58%
Intoxication
58%
Marker
58%
Retinoic Acid Receptor Alpha
41%
Therapeutic Procedure
38%
Tretinoin
33%
Ascending Aorta
25%
Gene
24%
Magnetic Resonance Imaging
23%
Pathogenesis
16%
Myeloid Differentiation
16%
Granulocyte
16%
Repressor Gene
16%
Chimeric Protein
16%
Allograft
15%
Immunosuppressive Treatment
15%
Valve Prosthesis
12%
Systole
12%
Volunteer
12%
Cells
10%
Glia Cell
10%
Spontaneous Remission
8%
Programmed Cell Death
8%
High Risk Population
8%
Differentiation
8%
Bleeding
8%
Anthracycline
8%
Myelodysplastic Syndrome
8%
Ligand
8%
Toxicity
8%
Molecularly Targeted Therapy
8%
Therapeutic Agent
8%
Minimal Residual Disease
8%
Chemotherapy
8%
Blood Clotting
6%
Heart Output
6%
Heart Cycle
6%
Electrocardiogram
6%
Aortic Valve Replacement
6%
Valve Replacement
6%
Lung Closing Volume
6%
Hemolysis
6%
Neuroscience
Parkinson's Disease
58%
Tetrahydropyridine
58%
Striatum
26%
Immunosuppression
15%
Cell Line
10%
Glia
10%
Magnetic Resonance Imaging
10%
Neuron
5%
Hypokinesia
5%
Grafting
5%
